
Hundreds of thousands of children have type 1 diabetes. Now, there's a Barbie who has it, too
Dollmaker Mattel worked with Breakthrough T1D, formerly known the Juvenile Diabetes Research Foundation, to design the doll, which aims to represent the roughly 304,000 kids and teens living with type 1 diabetes in the United States.
The doll launched Tuesday at the Breakthrough T1D Children's Congress, a three-day event in Washington that brings in kids and teens living with the condition to meet with lawmakers. This year, they're asking Congress to renew funding for the Special Diabetes Program, which was first allocated by Congress in 1997. The program's current funding ends after September.
The advocacy efforts have taken on new urgency this year. With so many deep cuts to federally funded projects in recent months, Breakthrough T1D said it's anxiously watching to see if this funding will be reupped.
Type 1 diabetes is an autoimmune disease, meaning the body mistakenly attacks its own organs and tissues. In this case, rough antibodies go after cells in the pancreas that make insulin, an essential hormone that helps the body turn food into energy. As a result, the body doesn't make enough of its own insulin, so people have to take insulin by injection or though a pump to survive.
Type 1 diabetes is typically diagnosed in childhood but can be diagnosed in anyone at any age. It differs from type 2 diabetes, in which people are still able to make insulin but their cells stop responding to it.
In addition to the insulin pump that attaches to the new Barbie's waist, the chestnut-haired beauty has a continuous glucose monitor on her arm – a button held on by a strip of heart-shaped Barbie-pink tape. Her cell phone displays an app that shows her glucose readings. She also has a light blue purse to hold her supplies and snacks to help her manage her blood sugar throughout the day. It matches her shoes, of course.
Emily Mazreku, director of marketing and communications at Breakthrough T1D, lives with type 1 diabetes and worked with Mattel to design the doll. Barbie's phone app displays a snapshot of her actual blood sugar readings from one day during the design process. Barbie's blood glucose reading is 130 milligrams of sugar per deciliter of blood, which is in the normal range. Most people with diabetes try to keep their blood sugar between 70 and 180 mg/dl.Her continuous glucose monitor has a graph that shows the highs and lows that can happen during the day. The blue polka dots are nods to the colors and symbols for diabetes awareness.
Mazreku spent almost two years holding focus groups to get feedback about the features of the doll and to make sure it was representing the entire type 1 diabetes community.
'Mattel approached us, and they wanted this to be a part of their Fashionista line,' Mazreku said. 'And we jumped on that opportunity right away.'
The line has dolls with more than 175 different looks, including a variety of skin tones, eye and hair colors. It includes a Barbie with behind-the-ear hearing aids, a blind doll who uses a cane and another with a prosthetic leg. There's also a doll with vitiligo, a condition in which skin loses its pigment and becomes splotchy.
'We know that increasing the number of people who can see themselves in Barbie continues to resonate,' said Devin Duff, a spokesperson for Mattel, in an email to CNN.
The company said the blind Barbie and a doll with Down syndrome were among the most popular Fashionista dolls globally in 2024.
The company launched its first doll with a disability — a friend for Barbie called Share-a-smile Becky, who used a wheelchair — in 1997. Customers noted at the time that Becky's wheelchair couldn't fit through the doors of the Barbie Dream House, a situation many people with disabilities encounter in real life.
That insight is part of the value of having kids play with dolls that have disabilities, said Dr. Sian Jones, co-founder of the Toy Box Diversity Lab at Queen Margaret University in Edinburgh, Scotland.
Jones and her colleague Dr. Clare Uytman study how playing with dolls and toys with a range of physical challenges can reduce systemic inequality for disabled people.
It's based on a theory of mirrors and windows by Rudine Sims Bishop, a professor emerita of education at Ohio State University. Bishop realized that having diverse characters in books was good for all kids: It helps children from minority groups see themselves mirrored in the lives of book characters, and it gives kids a window into the lives of others, helping them build empathy.
Jones says that when kids play with dolls that have mobility challenges, for example, it helps them identify and understand the struggles of people with disabilities whom they meet in real life.
'Barbie in a wheelchair cannot use the doll's house in their kindergarten classroom, so they have to build a ramp in order for her to be able to access the door to their doll's house, for example,' said Jones, who lives with cerebral palsy.
When she started her work incorporating disabled dolls into school curricula, Jones said, there were few available for purchase. She mostly had to make them herself. Now, she can buy them from big companies like Lego and Mattel, 'which is wonderful.'
Mazreku says the work to design the doll was well worth it. She recently got to bring one home to give to her 3-year-old daughter.
'I brought Barbie home to her and gave her a chance to interact with her and see her things,' Mazreku said. 'And she looked at me and she said, 'She looks like Mommy.' And that was so special for me.'
Her daughter doesn't have type 1 diabetes, she said. 'But she sees me every day, living with it, representing and understanding and showing the world and wearing my devices confidently, and for her to see Barbie doing that was really special.'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


New York Times
40 minutes ago
- New York Times
Arizona Resident Dies From Plague, Officials Say
A resident of Coconino County, Ariz., died from pneumonic plague, the first such death in the county in almost two decades, officials announced on Friday. The resident went to Flagstaff Medical Center recently and died the same day despite attempts to provide 'lifesaving resuscitation,' according to a statement on Friday from Northern Arizona Healthcare, which runs the hospital. Rapid diagnostic testing confirmed that the patient was infected with Yersinia pestis, the bacteria that causes the pneumonic plague, which appears as a severe lung infection. It was the first recorded death from the pneumonic plague in Coconino County, which is north of Phoenix, since 2007, county officials said in a statement. Additional details about the case, including when the patient died, were not released. The risk of exposure to the plague remains low, officials said. It's rare for cases of the disease to appear in humans, according to the federal Centers for Disease Control and Prevention. Plague occurs naturally in the western United States and circulates among the rodent populations there, the agency said. The plague infamously struck Europe in the 1340s, killing large parts of the continent's population. The outbreak began in a trader settlement in what is now Kyrgyzstan before spreading across Eurasia. The outbreak was known as the Black Death, for the black spots that appeared on the bodies of the sick, who were infected with Yersinia pestis after being bitten by fleas that lived on rodents. According to Arizona officials, the 2007 death happened after the person came into contact with a dead animal infected with plague. Humans are usually infected through the bite of an infected rodent flea or by handling an infected animal, the C.D.C. said. An average of seven human plague cases are reported each year in the United States, according to the agency. Pneumonic plague symptoms include fever, headache and rapidly developing pneumonia, with shortness of breath, chest pain and coughing. Symptoms develop within one to eight days of exposure. Plague can be cured through antibiotics, but the treatment must be given quickly, according to the C.D.C. The risk of human-to-human transmission of the plague is low and the last known case happened in 1924 in Los Angeles, according to the National Institutes of Health. Plague is one of many diseases endemic to the southwestern United States, including West Nile virus, hantavirus and rabies. In New Mexico, Betsy Arakawa, the wife of the actor Gene Hackman, died from hantavirus this year, most likely after coming into contact with infected rodents.
Yahoo
40 minutes ago
- Yahoo
Cardinal Health (NYSE:CAH) Launches One Voice Initiative Supporting Independent Pharmacy Advocacy
Cardinal Health recently launched its Cardinal Health™ One Voice Initiative, a move aimed at advocating for independent pharmacies, which aligns with the company's broader strategic efforts in product development and community support. Over the last quarter, the company's stock price rose by 22%, reflecting not only this initiative but also the increased dividend payout, which may have appealed to income-focused investors. Furthermore, Cardinal Health's inclusion in the Russell 1000 indices and a significant uptick in earnings contributed positively to investor sentiment. These developments collectively underscore the company's ability to enhance shareholder value in a relatively stable market. We've identified 1 risk for Cardinal Health that you should be aware of. These 14 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch. The One Voice Initiative reflects well on Cardinal Health's commitment to its independent pharmacy customers and could help bolster its brand reputation and customer satisfaction. This initiative, alongside a stronger dividend payout, aligns with its strategic emphasis on enhancing community support and product development. Over the past five years, Cardinal Health's total shareholder return, including dividends, was approximately 246.58%. This performance over the period positively positions it against the one-year broader US Healthcare industry return of 22.1% decline, demonstrating significant resilience and competitive strength. The company's strategic acquisitions and expanded manufacturing capabilities are pivotal in enhancing revenue streams. Analysts forecast annual revenue growth of 8.1%, underlined by strong performance in segments like Specialty Solutions and the onboarding of key clients like Publix. Earnings are projected to grow from US$1.6 billion to US$2 billion by May 2028. However, tariff risks and macroeconomic challenges could challenge these forecasts by impacting margins and cost structures. With a current share price of US$151.69, a discount to the consensus price target of US$175.81 suggests the market might anticipate future growth to align with analyst projections. The forecast earnings growth and other operational improvements support a fair valuation, though investors should balance these expectations with potential tariff impacts and broader economic volatility. This careful balance will likely influence Cardinal Health's trajectory in aligning with or exceeding the industry benchmarks in the coming years. Gain insights into Cardinal Health's future direction by reviewing our growth report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:CAH. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@


Geek Wire
an hour ago
- Geek Wire
‘We will go on': Global health nonprofit PATH navigates U.S. funding freeze from new Seattle HQ
PATH's ribbon-cutting ceremony this week should have been purely celebratory. Instead, the global health nonprofit's move to airy new Seattle offices overlooking a tree-lined ship canal came as the venerable institution is finding its footing after six months of unprecedented turmoil. On the first day of his second term, President Trump froze all foreign aid. A week later, he began dismantling the U.S. Agency for International Development (USAID) — a move that could lead to 14 million additional deaths worldwide by the end of this decade, according to new research. The U.S. government has canceled awards to the organization and stalled on payments. PATH laid off roughly 45% of its global workforce, shrinking its current headcount to 1,700. 'We will go on,' Nikolaj Gilbert, president and CEO of PATH, told GeekWire. 'We will go on strong because the needs are still there, they haven't disappeared. So it's for us to challenge ourselves to see how can we continue to have even more impact with less resources.' PATH occupies a unique space in the global health sphere, doing research and testing to develop life-saving vaccines, diagnostics and medical supplies, as well as providing support for effective healthcare systems — all targeting low- and middle-income countries worldwide. It partners closely with foreign health ministries, philanthropies including the Gates Foundation, and major pharmaceutical and other companies to deliver on a mission that began nearly 50 years ago. Roger Peck, PATH's associate director of diagnostics, on a tour of the nonprofit's new lab. (GeekWire Photo / Lisa Stiffler) Navigating the aftermath The nonprofit is charting its course from the new headquarters as staff navigate the aftermath of Trump administration cuts, with the final scope of reductions still unknown. Gilbert last month shared that the nonprofit had awards for 53 U.S.-funded projects at the start of the year. By the end of May, 28 were active and 23 had been terminated; the organization did not provide an updated status. PATH expects funding from U.S. government awards to comprise 18% of its total revenue this year, down from 36% last year. The Gates Foundation remains its largest funder. Since its launch in 1977 as the Program for Appropriate Technology in Health, PATH has led and collaborated on innovations that have benefited millions of impoverished people, including: Beyond developing critical technologies, PATH works to ensure products remain affordable, reduce waste in healthcare supplies, and build local supply chains for drugs and diagnostic testing. The nonprofit is also building its artificial intelligence capabilities, hiring Bilal Mateen as its first chief AI officer nearly a year ago. PATH's AI initiatives include accelerating drug and diagnostic development and engineering an assistant to guide healthcare providers treating patients in remote areas. PATH front desk. (GeekWire Photo / Lisa Stiffler) Innovation continues despite constraints PATH operates in 70 countries through dozens of offices worldwide. More than a year ago, the organization recognized an opportunity to downsize its Seattle base as employees shifted to hybrid work following the COVID pandemic. The move from South Lake Union to Fremont cut its footprint nearly in half, from 113,000 to 52,000 square feet. But the March relocation to former Google offices wasn't just about saving space. PATH expanded its specialized lab facilities for vaccine and disease work by 20%, bringing the wet-lab area to 6,000 square feet with capacity for about 20 scientists. On a recent tour of the facility, Roger Peck, PATH's associate director of diagnostics, pointed out the wide range of scientific devices and the modular design of the infrastructure that allows for easy reconfiguration as the field evolves. 'What differentiates us is the type of work that we do here and the variety of work,' Peck said. That includes research in immunology, molecular diagnostic tests, vaccine formulations and other initiatives. The other side of the building is occupied by PATH's Product Development Engineering Lab, which feels like a makerspace and includes 3D printers, life-sized baby dolls for testing devices meant for infants and children, fabricating technologies and refrigerating systems. 'This is a really special facility because we have the capability to do complete in-house, end-to-end medical device development,' said Clara Orndorff, a global health design engineer. 'So we can do everything from prototyping to building, regulated testing to redesign, and technology transfer. In many places that would require you go to four or five different contractors.' Clara Orndorff, PATH product development engineer, explaining the mechanics of a freeze-preventive vaccine carrier, a simple but impactful device designed by PATH. (GeekWire Photo / Lisa Stiffler) Building for the future The remainder of PATH's headquarters features glass-windowed conference rooms, a spacious kitchen area that flows into an event space, offices and desks, and a casual meeting area with comfy chairs and books. Large, multimedia artwork from around the world brightens the walls and hallways. On the day of the ribbon-cutting, PATH leaders struck a tone of optimism, noting that the challenges present an opportunity for change. 'The fragility of this sector is something we could not have imagined before January of this year,' Kammerle Schneider, chief of Global Health Programs at PATH, told GeekWire. The realization has spurred PATH to accelerate long-discussed plans for creating more sustainable healthcare ecosystems and shifting the ownership of solutions to local communities. 'It's a time,' Schneider said, 'of being much more bold than perhaps we've been in the past.' Continue scrolling for additional photos. A cozy spot for informal conversations at PATH's Seattle office. (GeekWire Photo / Lisa Stiffler) PATH's entrance. (GeekWire Photo / Lisa Stiffler)